- Home
- GHRS vs HTFL Comparison
GHRS vs HTFL Comparison
Compare GHRS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | HTFL |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GHRS | HTFL |
|---|---|---|
| Price | $18.22 | $48.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | $42.89 | ★ $47.22 |
| AVG Volume (30 Days) | 299.1K | ★ 1.5M |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | N/A | $41.33 |
| Revenue Next Year | N/A | $24.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $12.04 | $20.13 |
| 52 Week High | $31.44 | $54.32 |
Technical Indicators
Market Signals| Indicator | GHRS | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 22.04 | 49.10 |
| Support Level | $13.58 | $46.46 |
| Resistance Level | $22.88 | $52.38 |
| Average True Range (ATR) | 1.19 | 2.68 |
| MACD | -0.33 | -0.37 |
| Stochastic Oscillator | 2.31 | 24.23 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.